Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Rang in aandelen #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Aandeelprijs
$154.51
Marktkapitalisatie
$55.98B
Verandering (1 dag)
-1.82%
Verandering (1 jaar)
-32.08%
Land
US
Handel Becton, Dickinson and Company (BDX)

Categorie

Aantal uitstaande aandelen voor Becton, Dickinson and Company (BDX)
Aantal uitstaande aandelen per December 2025: 285.07M
Volgens de laatste financiële rapporten en de aandelenkoers van Becton, Dickinson and Company bedraagt het huidige aantal uitstaande aandelen 285.07M. Aan het einde van September 2024 had het bedrijf 289.76M uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Becton, Dickinson and Company (BDX) van 2000 tot 2026
Uitstaande aandelen aan het einde van elk jaar
Jaar Uitstaande aandelen Wijzigen
2026 (TTM) 285.07M -0.54%
2025 286.61M -1.09%
2024 289.76M 1.22%
2023 286.28M 0.45%
2022 285.01M -1.48%
2021 289.29M 3.70%
2020 278.97M 3.34%
2019 269.94M 4.49%
2018 258.35M 18.00%
2017 218.94M 2.93%
2016 212.70M 5.02%
2015 202.54M 4.78%
2014 193.30M -0.95%
2013 195.16M -5.01%
2012 205.46M -7.11%
2011 221.18M -5.61%
2010 234.33M -2.56%
2009 240.48M -1.57%
2008 244.32M -0.35%
2007 245.19M -0.92%
2006 247.46M -1.62%
2005 251.53M 0.01%
2004 251.51M -1.19%
2003 254.54M -1.37%
2002 258.07M 0.27%
2001 257.37M 1.64%
2000 253.23M 0.00%
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
Bedrijf Uitstaande aandelen Verschil Land
354.90M 24.49%
US
345.26M 21.11%
DE
338.57M 18.77%
JP
489.30M 71.64%
CH
146.47M -48.62%
US